Performance marketing for neurotech doesn't work like performance marketing for SaaS. Your buyers are niche, your claims are regulated, and your sales cycle outlasts most attribution windows. We build paid media programs that generate qualified pipeline for neurotech companies, not just impressions.
The Problem
Standard paid media playbooks don't work for neurotech
Your digital marketing agency is running the same Google Ads and LinkedIn campaigns they run for every B2B client. But neurotech audiences are tiny, highly specialized, and don't respond to generic demand-gen tactics. When your total addressable audience of neurologists interested in neurostimulation devices fits in a conference hall, broad targeting wastes budget on irrelevant clicks. You need a performance marketing approach built for niche, technical markets.
FDA compliance kills your ad copy before it launches
Every claim in a neurotech ad needs to be substantiated and compliant with FDA regulations. Your marketing team writes compelling copy, legal redlines it into something nobody would click on, and the cycle repeats. Most performance marketing agencies don't understand regulatory constraints and keep submitting non-compliant creative. The result is either ads that say nothing or a team that stops trying to run paid media altogether.
Your attribution model can't handle an 18-month sales cycle
Standard attribution gives credit to the last click before a conversion. But in neurotech, a prospect might see a LinkedIn ad in January, download a whitepaper in March, attend a conference demo in June, and close a deal in October. If your attribution model only tracks the last 30 days, you're making budget decisions based on incomplete data. You think paid media isn't working when it actually sourced the deal — you just can't see it.
You're measuring clicks and impressions instead of pipeline
Your agency reports show CTR improvements and cost-per-click reductions, but your sales team says the leads are garbage. This disconnect happens because performance marketing is being optimized for platform metrics rather than business outcomes. In neurotech, a single qualified opportunity is worth more than ten thousand unqualified clicks. If your paid media program isn't measured against pipeline and revenue, it's measured against the wrong things.
How We Help
We start by defining what a qualified lead actually looks like for your neurotech company. This sounds basic, but most teams haven't aligned on it. We work with your sales team to define qualification criteria based on title, institution type, clinical application, and buying authority. Every dollar of paid media spend targets this profile, not a loose proxy.
Channel strategy for neurotech performance marketing is fundamentally different from standard B2B. Google Ads work for bottom-funnel capture when clinicians are actively researching solutions, but the search volume is tiny. LinkedIn offers precise professional targeting but at premium CPMs. Programmatic display through healthcare-specific networks reaches clinical audiences in context. Conference and event retargeting captures the high-intent audience that attended your demo. We build a channel mix based on your specific audience, budget, and sales cycle stage.
Creative development includes a regulatory compliance framework. We build ad copy templates with pre-approved claim structures that your legal team signs off on once. Individual ads are then built within those frameworks, which means faster approval cycles and more creative throughput. For neurotech, the most effective ads lead with the clinical problem rather than the product — a neurologist cares about treatment-resistant depression outcomes, not your device's specifications.
Landing page strategy is where most neurotech paid media programs fail. Sending a clinician to your homepage after they click an ad about a specific clinical application is a conversion killer. We build dedicated landing pages for each campaign that match the ad's promise, speak directly to the audience, and offer a conversion action appropriate to their stage — a clinical evidence summary for early-stage interest, a consultation request for high-intent prospects.
Attribution and measurement are engineered for long sales cycles. We implement multi-touch attribution that tracks the full buyer journey across digital touchpoints, offline events, and sales interactions. This means you can see that the LinkedIn ad six months ago influenced the deal that just closed. We connect paid media data to your CRM so pipeline and revenue attribution are visible alongside platform metrics.
Optimization happens at the pipeline level, not the platform level. We don't optimize for cost-per-click — we optimize for cost-per-qualified-opportunity. That sometimes means paying more per click to reach a better audience, or running campaigns with low CTR but high conversion to sales-qualified leads. The math is different when a single deal is worth six or seven figures.
Reporting is built for operators, not slide decks. You get a weekly dashboard showing spend, pipeline generated, and cost per qualified opportunity. Monthly reviews assess channel performance, creative performance, and audience insights. Quarterly strategy sessions adjust the plan based on what the data tells us about your market and your competitors.
What we deliver
- Performance marketing strategy — channel mix, audience targeting, budget allocation, and compliance framework
- Campaign execution — ad creative, landing pages, conversion tracking, and ongoing optimization across all channels
- Attribution infrastructure — multi-touch attribution model connected to CRM with pipeline and revenue tracking
- Performance reporting — weekly dashboards, monthly reviews, and quarterly strategy optimization
In neurotech, a $50 cost-per-click that generates a $500K deal is infinitely better than a $5 cost-per-click that generates a mailing list of grad students. Performance marketing for niche markets means optimizing for pipeline value, not platform metrics.
Our Methodology
The 90-day sprint builds your performance marketing engine in three phases. Days 1-30 are strategy and infrastructure: audience definition, channel selection, compliance framework development, attribution setup, and CRM integration. We don't launch a single ad until the measurement infrastructure is in place because we need clean data from day one.
Days 31-60 are launch and testing. We run initial campaigns across the selected channels, test multiple audiences, creative approaches, and landing pages. In neurotech, testing cycles are longer because the audience is small — you can't A/B test with statistical significance in a week when your total audience is 10,000 people. We use structured testing frameworks designed for small-audience markets.
Days 61-90 are optimization and scaling. Based on the first month of campaign data and CRM-tracked pipeline results, we reallocate budget to winning channels and audiences, refine creative, and expand targeting where the data supports it. By day 90, you have a running performance marketing program with proven channels, compliant creative, and clear pipeline attribution.
How We Work
A performance marketing engagement includes a channel strategist, a creative specialist with healthcare marketing experience, and a marketing operations lead who handles attribution and CRM integration. Your team commitment is 2-3 hours per week for strategy alignment and legal review, front-loaded in month one.
Budget requirements vary by channel mix and audience size. We recommend a minimum of $10K-$25K per month in media spend for neurotech companies — the audience is small and CPMs are higher than broad B2B. Management fees are separate and scale with program complexity.
Cadence includes weekly performance check-ins, monthly strategy reviews, and quarterly planning. We manage day-to-day operations — bid adjustments, creative rotation, budget pacing — so your team isn't logging into ad platforms.
Expect a ramp period. Performance marketing in neurotech doesn't produce instant results because the audience is niche and sales cycles are long. The first 60 days build the data foundation. Months three through six show pipeline impact. Clients who commit to six months get significantly better results than those evaluating on a 90-day window.
- Qualified pipeline generated through paid channels with clear attribution to specific campaigns and audiences
- Regulatory-compliant ad creative that performs and passes legal review without repeated revision cycles
- Data-driven budget allocation based on cost-per-qualified-opportunity rather than vanity metrics
If your neurotech company needs performance marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does performance marketing cost for neurotech companies?
Management fees typically run $8K-$20K per month depending on channel complexity and creative volume. Media spend is additional and varies by your goals and audience size — most neurotech clients invest $10K-$25K per month in paid media. Total cost is a fraction of a full-time demand generation hire, and you get a team instead of one person. The ROI math works when a single enterprise deal covers months of investment.
How long before we see results from performance marketing?
Lead flow starts within the first 30 days of campaign launch. Qualified pipeline takes 60-90 days to materialize because neurotech buyers don't convert from ad-to-demo in one session. Revenue impact follows your sales cycle — typically 6-12 months for enterprise deals. We set up leading indicators at each stage so you can track progress well before deals close.
How does the performance marketing team integrate with our existing staff?
We run the campaigns and handle all platform operations. Your team provides clinical and technical input for creative development and handles legal review. We integrate with your sales team to track lead quality and pipeline progression. If you have an internal marketing person, we work alongside them and can train them on the system. Our goal is to build a program your team can eventually manage independently.
What makes Winston Francois different from a traditional performance marketing agency?
Most performance marketing agencies optimize for platform metrics because that's what they know how to measure. We optimize for pipeline because that's what matters. We also know how to run compliant campaigns in regulated industries — our creative process includes a regulatory framework that most agencies don't have. And we build attribution for long sales cycles instead of defaulting to 30-day last-click models.
How do you measure ROI from a performance marketing engagement?
Primary metric is cost per qualified opportunity — how much did we spend to generate a prospect your sales team is actively working? Secondary metrics include pipeline value generated, influence on closed-won deals, and channel-specific efficiency. We report against these weekly and make budget decisions based on opportunity data, not click data. If a channel is generating clicks but not pipeline, we redirect that spend.
What type of neurotech company is the right fit for this service?
Companies with an FDA-cleared or near-market product that are actively selling to a defined buyer persona. You need a product to promote and a sales team to follow up on leads. Pre-clinical companies are too early — you need content marketing and thought leadership before performance marketing. Companies with a price point above $50K per deal are ideal because the unit economics support paid acquisition at neurotech CPMs.
